Skip to main content
. 2021 Dec 22;11(1):e020244. doi: 10.1161/JAHA.120.020244

Table 3.

Comparison of Alive and Deceased Patients with Acute Coronary Syndrome

Parameter Alive, N=929, N (%) Deceased, N=143, N (%) P value*
Male 620 (66.7) 96 (67.1) 0.926
Age ≥60 y 475 (51.1) 75 (52.4) 0.995
Low socioeconomic class 149 (16.1) 47 (32.9) <0.0001
Family history of CAD 185 (21.5) 12 (9.4) 0.001
Metabolic syndrome 354 (47.6) 44 (41.5) 0.241
Atypical symptoms (epigastric pain/dyspepsia) 130 (14.1) 33 (23.2) 0.01
Troponin positive 505 (72.3) 72 (85.7) 0.009
STEMI 432 (46.5) 90 (62.9) <0.0001
Renal impairment 107 (13.2) 36 (31.9) <0.0001
Diastolic dysfunction 527 (63.8) 79 (65.5) 0.002
Multivessel disease 209 (38.3) 20 (48.0) 0.194
Pulmonary edema 174 (21.2) 64 (47.8) <0.0001
Cardiogenic shock 60 (7.4) 44 (30.6) <0.0001
Intracardiac clot 45 (5.5) 20 (15.3) <0.0001
Resuscitated cardiac arrest 10 (1.2) 28 (21.1) <0.0001
Stroke 174 (9.1) 17 (12.9) 0.171
Intervention (thrombolysis/PCI/CABG) 409 (44.0) 107 (18.8) <0.0001
Mean (SD) Mean (SD) P value
HR 83.8 (19.1) 100.7 (25.2) <0.0001
SBP 135 (24.2) 120.4 (27.5) <0.0001
DBP 81.9 (15.3) 76.8 (17.9) <0.0001
PCV 40 (5.5) 37.6 (7.8) <0.0001
LVEF 49.9 (26.7) 37.4 (12.6) <0.0001

CABG indicates coronary artery bypass graft; CAD, coronary artery disease; DBP, diastolic blood pressure; HR, heart rate; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PCV, packed cell volume; SBP, systolic blood pressure; and STEMI, ST‐segment–elevation myocardial infarction.

* P value derived from χ2 test.

P value is significant.

P value derived from independent t test.